
Moderna’s COVID-19 vaccine has received full approval for use in people 18 and older, the U.S. Food and Drug Administration announced Monday. The vaccine, which has been available for that age group under emergency use authorization (EUA), will be marketed as Spikevax. It’s not yet fully approved or authorized for use in people younger than… read on > read on >